Drug information for PENTAMIDINE ISETHIONATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 300MG/VIAL Discontinued   PENTAMIDINE ISETHIONATE Pentamidine HOSPIRA 73479
2007-07-09 Review
INJECTABLE; INJECTION 300MG/VIAL Discontinued   PENTAMIDINE ISETHIONATE Pentamidine BAXTER HLTHCARE 73617
INJECTABLE; INJECTION 300MG/VIAL Prescription AP  PENTAMIDINE ISETHIONATE Pentamidine WATSON LABS 74303

Drug Adverse Effects information for PENTAMIDINE ISETHIONATE

Role code Indications Reaction # Reports
PS IMMUNOSUPPRESSION DRUG INTERACTION 3
PS IMMUNOSUPPRESSION LIPIDS INCREASED 3
PS PNEUMOCYSTIS JIROVECI PNEUMONIA DRUG INTERACTION 1
PS PNEUMOCYSTIS JIROVECI PNEUMONIA LIPIDS INCREASED 1
PS PNEUMONIA ALVEOLITIS 1
PS PNEUMONIA BLOOD PRESSURE INCREASED 1
PS PNEUMONIA BRONCHIECTASIS 1
PS PNEUMONIA CONFUSIONAL STATE 1
PS PNEUMONIA CONVULSION 1
PS PNEUMONIA DIFFUSE ALVEOLAR DAMAGE 1
PS PNEUMONIA DRUG INTERACTION 5
PS PNEUMONIA FIBROSIS 1
PS PNEUMONIA GRANULOMA 1
PS PNEUMONIA HAEMODIALYSIS 1
PS PNEUMONIA HYPERKALAEMIA 1
PS PNEUMONIA KIDNEY FIBROSIS 1
PS PNEUMONIA LIPIDS INCREASED 6
PS PNEUMONIA OBLITERATIVE BRONCHIOLITIS 1
PS PNEUMONIA ORGANISING PNEUMONIA 1
PS PNEUMONIA PLATELET COUNT DECREASED 1
PS PNEUMONIA PNEUMONIA ASPIRATION 1
PS PNEUMONIA PNEUMONITIS 1
PS PNEUMONIA POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
PS PNEUMONIA POTENTIATING DRUG INTERACTION 1
PS PNEUMONIA PULMONARY FIBROSIS 1
PS PNEUMONIA PULMONARY TOXICITY 1
PS PNEUMONIA RENAL FAILURE 1
PS PNEUMONIA RENAL TUBULAR ATROPHY 1
PS PNEUMONIA RESPIRATORY DISTRESS 1
PS PNEUMONIA THROMBOTIC MICROANGIOPATHY 1
PS PNEUMONIA TOXICITY TO VARIOUS AGENTS 1
PS PNEUMONIA VISUAL ACUITY REDUCED 1
PS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 9
PS PRODUCT USED FOR UNKNOWN INDICATION LIPIDS INCREASED 9
SS IMMUNOSUPPRESSION DRUG INTERACTION 3
SS IMMUNOSUPPRESSION LIPIDS INCREASED 3
SS PNEUMOCYSTIS JIROVECI PNEUMONIA DRUG INTERACTION 1
SS PNEUMOCYSTIS JIROVECI PNEUMONIA LIPIDS INCREASED 1
SS PNEUMONIA DRUG INTERACTION 5
SS PNEUMONIA LIPIDS INCREASED 5
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 9
SS PRODUCT USED FOR UNKNOWN INDICATION LIPIDS INCREASED 9
C APLASTIC ANAEMIA ASPERGILLOSIS 2
C APLASTIC ANAEMIA BACTERIAL INFECTION 2
C APLASTIC ANAEMIA CANDIDIASIS 2
C APLASTIC ANAEMIA CHRONIC GRAFT VERSUS HOST DISEASE 2
C APLASTIC ANAEMIA CYTOMEGALOVIRUS INFECTION 2
C APLASTIC ANAEMIA LIVER DISORDER 2
C APLASTIC ANAEMIA PYREXIA 2
C APLASTIC ANAEMIA VIRAL INFECTION 2
C ASPERGILLOSIS ASPERGILLOSIS 7
C ASPERGILLOSIS BACTERIAL INFECTION 7
C ASPERGILLOSIS CANDIDIASIS 7
C ASPERGILLOSIS CHRONIC GRAFT VERSUS HOST DISEASE 7
C ASPERGILLOSIS CYTOMEGALOVIRUS INFECTION 7
C ASPERGILLOSIS LIVER DISORDER 7
C ASPERGILLOSIS PYREXIA 7
C ASPERGILLOSIS VIRAL INFECTION 7
C BONE MARROW CONDITIONING REGIMEN ASPERGILLOSIS 1
C BONE MARROW CONDITIONING REGIMEN BACTERIAL INFECTION 1
C BONE MARROW CONDITIONING REGIMEN CANDIDIASIS 1
C BONE MARROW CONDITIONING REGIMEN CHRONIC GRAFT VERSUS HOST DISEASE 1
C BONE MARROW CONDITIONING REGIMEN CYTOMEGALOVIRUS INFECTION 1
C BONE MARROW CONDITIONING REGIMEN LIVER DISORDER 1
C BONE MARROW CONDITIONING REGIMEN PYREXIA 1
C BONE MARROW CONDITIONING REGIMEN VIRAL INFECTION 1
C CANDIDIASIS ASPERGILLOSIS 7
C CANDIDIASIS BACTERIAL INFECTION 7
C CANDIDIASIS CANDIDIASIS 7
C CANDIDIASIS CHRONIC GRAFT VERSUS HOST DISEASE 7
C CANDIDIASIS CYTOMEGALOVIRUS INFECTION 7
C CANDIDIASIS LIVER DISORDER 7
C CANDIDIASIS PYREXIA 7
C CANDIDIASIS VIRAL INFECTION 7
C CYTOMEGALOVIRUS CHORIORETINITIS BLOOD ALKALINE PHOSPHATASE INCREASED 2
C CYTOMEGALOVIRUS CHORIORETINITIS BRONCHOPULMONARY ASPERGILLOSIS 2
C CYTOMEGALOVIRUS CHORIORETINITIS CYTOMEGALOVIRUS CHORIORETINITIS 2
C CYTOMEGALOVIRUS CHORIORETINITIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
C CYTOMEGALOVIRUS CHORIORETINITIS LYMPHOMA 2
C CYTOMEGALOVIRUS CHORIORETINITIS PLATELET COUNT DECREASED 2
C DIABETES MELLITUS BACK PAIN 2
C DIABETES MELLITUS CALCULUS URETERIC 2
C DIABETES MELLITUS CHILLS 2
C DIABETES MELLITUS FEELING HOT 2
C DIABETES MELLITUS PYELONEPHRITIS ACUTE 2
C DIABETES MELLITUS PYURIA 2
C HEART TRANSPLANT REJECTION EPILEPSY 1
C HEART TRANSPLANT REJECTION GRANULOCYTOPENIA 1
C HEART TRANSPLANT REJECTION HAEMOGLOBIN DECREASED 1
C HEART TRANSPLANT REJECTION STAPHYLOCOCCAL INFECTION 1
C HEART TRANSPLANT REJECTION UTERINE LEIOMYOMA 1
C HEART TRANSPLANT REJECTION WHITE BLOOD CELL COUNT DECREASED 1
C HIV INFECTION AGGRESSION 1
C HIV INFECTION AGITATION 1
C HIV INFECTION ALOPECIA 1
C HIV INFECTION ANAEMIA HAEMOLYTIC AUTOIMMUNE 1
C HIV INFECTION ARTHRALGIA 1
C HIV INFECTION ATELECTASIS 1
C HIV INFECTION BACK PAIN 8
C HIV INFECTION BLOOD ALBUMIN DECREASED 1
C HIV INFECTION BLOOD ALKALINE PHOSPHATASE INCREASED 12
C HIV INFECTION BLOOD BILIRUBIN INCREASED 8
C HIV INFECTION BRONCHIECTASIS 1
C HIV INFECTION BRONCHOPULMONARY ASPERGILLOSIS 12
C HIV INFECTION C-REACTIVE PROTEIN INCREASED 8
C HIV INFECTION CALCULUS URETERIC 8
C HIV INFECTION CHILLS 8
C HIV INFECTION CYANOSIS 1
C HIV INFECTION CYTOMEGALOVIRUS CHORIORETINITIS 12
C HIV INFECTION DEAFNESS 1
C HIV INFECTION DEHYDRATION 1
C HIV INFECTION DEPRESSION 1
C HIV INFECTION DIABETIC KETOACIDOSIS 1
C HIV INFECTION DIARRHOEA 1
C HIV INFECTION DISEASE RECURRENCE 1
C HIV INFECTION EAR DISORDER 1
C HIV INFECTION EAR INFECTION 1
C HIV INFECTION ELECTROCARDIOGRAM QT PROLONGED 1
C HIV INFECTION ELECTROLYTE IMBALANCE 1
C HIV INFECTION ENCEPHALOPATHY 1
C HIV INFECTION EXFOLIATIVE RASH 1
C HIV INFECTION FACE OEDEMA 1
C HIV INFECTION FEELING HOT 8
C HIV INFECTION FLUID OVERLOAD 1
C HIV INFECTION FUNGAEMIA 1
C HIV INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
C HIV INFECTION HAEMOLYTIC URAEMIC SYNDROME 1
C HIV INFECTION HEPATIC STEATOSIS 1
C HIV INFECTION HERPES ZOSTER 1
C HIV INFECTION HYPOKALAEMIA 1
C HIV INFECTION HYPONATRAEMIA 1
C HIV INFECTION INDURATION 1
C HIV INFECTION JAUNDICE 8
C HIV INFECTION LETHARGY 1
C HIV INFECTION LYMPHOMA 12
C HIV INFECTION METABOLIC ACIDOSIS 1
C HIV INFECTION METAPNEUMOVIRUS INFECTION 1
C HIV INFECTION MYALGIA 1
C HIV INFECTION NYSTAGMUS 1
C HIV INFECTION OCULAR HYPERAEMIA 1
C HIV INFECTION OPPORTUNISTIC INFECTION 1
C HIV INFECTION OXYGEN SATURATION DECREASED 8
C HIV INFECTION PAIN 1
C HIV INFECTION PANCREATITIS 1
C HIV INFECTION PLATELET COUNT DECREASED 12
C HIV INFECTION PLEURAL EFFUSION 9
C HIV INFECTION PNEUMONIA 9
C HIV INFECTION PYELONEPHRITIS ACUTE 8
C HIV INFECTION PYURIA 8
C HIV INFECTION RASH ERYTHEMATOUS 1
C HIV INFECTION RASH GENERALISED 1
C HIV INFECTION RASH MACULO-PAPULAR 1
C HIV INFECTION RASH PRURITIC 1
C HIV INFECTION RENAL FAILURE ACUTE 1
C HIV INFECTION RESPIRATORY RATE INCREASED 1
C HIV INFECTION RHINOVIRUS INFECTION 1
C HIV INFECTION SEPSIS 1
C HIV INFECTION SUICIDAL IDEATION 1
C HIV INFECTION SWELLING 1
C HIV INFECTION TACHYCARDIA 1
C HIV INFECTION TACHYPNOEA 1
C HIV INFECTION THROMBOCYTOPENIA 1
C HIV INFECTION THROMBOTIC THROMBOCYTOPENIC PURPURA 1
C HIV INFECTION TOOTHACHE 1
C HIV INFECTION TOXICITY TO VARIOUS AGENTS 1
C HIV INFECTION TREATMENT NONCOMPLIANCE 1
C HIV INFECTION TREMOR 1
C HIV INFECTION TYPE 2 DIABETES MELLITUS 1
C HIV INFECTION WHITE BLOOD CELL COUNT INCREASED 8
C HYPERURICAEMIA BLOOD BILIRUBIN INCREASED 2
C HYPERURICAEMIA C-REACTIVE PROTEIN INCREASED 2
C HYPERURICAEMIA JAUNDICE 2
C HYPERURICAEMIA OXYGEN SATURATION DECREASED 2
C HYPERURICAEMIA PLEURAL EFFUSION 2
C HYPERURICAEMIA PNEUMONIA 2
C HYPERURICAEMIA WHITE BLOOD CELL COUNT INCREASED 2
C INFECTION PROPHYLAXIS ASPERGILLOSIS 14
C INFECTION PROPHYLAXIS BACTERIAL INFECTION 14
C INFECTION PROPHYLAXIS CANDIDIASIS 14
C INFECTION PROPHYLAXIS CHRONIC GRAFT VERSUS HOST DISEASE 14
C INFECTION PROPHYLAXIS CYTOMEGALOVIRUS INFECTION 14
C INFECTION PROPHYLAXIS LIVER DISORDER 14
C INFECTION PROPHYLAXIS PYREXIA 14
C INFECTION PROPHYLAXIS VIRAL INFECTION 14
C LIVER DISORDER ASPERGILLOSIS 3
C LIVER DISORDER BACTERIAL INFECTION 3
C LIVER DISORDER CANDIDIASIS 3
C LIVER DISORDER CHRONIC GRAFT VERSUS HOST DISEASE 3
C LIVER DISORDER CYTOMEGALOVIRUS INFECTION 3
C LIVER DISORDER LIVER DISORDER 3
C LIVER DISORDER PYREXIA 3
C LIVER DISORDER VIRAL INFECTION 3
C MENINGITIS ASPERGILLOSIS 7
C MENINGITIS BACTERIAL INFECTION 7
C MENINGITIS CANDIDIASIS 7
C MENINGITIS CHRONIC GRAFT VERSUS HOST DISEASE 7
C MENINGITIS CYTOMEGALOVIRUS INFECTION 7
C MENINGITIS LIVER DISORDER 7
C MENINGITIS PYREXIA 7
C MENINGITIS VIRAL INFECTION 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION BACK PAIN 6
C MYCOBACTERIUM AVIUM COMPLEX INFECTION CALCULUS URETERIC 6
C MYCOBACTERIUM AVIUM COMPLEX INFECTION CHILLS 6
C MYCOBACTERIUM AVIUM COMPLEX INFECTION FEELING HOT 6
C MYCOBACTERIUM AVIUM COMPLEX INFECTION PYELONEPHRITIS ACUTE 6
C MYCOBACTERIUM AVIUM COMPLEX INFECTION PYURIA 6
C OPPORTUNISTIC INFECTION PROPHYLAXIS BLOOD ALKALINE PHOSPHATASE INCREASED 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS BRONCHOPULMONARY ASPERGILLOSIS 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS CYTOMEGALOVIRUS CHORIORETINITIS 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS LYMPHOMA 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS PLATELET COUNT DECREASED 2
C ORAL CANDIDIASIS BLOOD BILIRUBIN INCREASED 2
C ORAL CANDIDIASIS C-REACTIVE PROTEIN INCREASED 2
C ORAL CANDIDIASIS JAUNDICE 2
C ORAL CANDIDIASIS OXYGEN SATURATION DECREASED 2
C ORAL CANDIDIASIS PLEURAL EFFUSION 2
C ORAL CANDIDIASIS PNEUMONIA 2
C ORAL CANDIDIASIS WHITE BLOOD CELL COUNT INCREASED 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA BACK PAIN 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA BLOOD BILIRUBIN INCREASED 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA C-REACTIVE PROTEIN INCREASED 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA CALCULUS URETERIC 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA CHILLS 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA FEELING HOT 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA JAUNDICE 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA OXYGEN SATURATION DECREASED 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA PLEURAL EFFUSION 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA PNEUMONIA 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA PYELONEPHRITIS ACUTE 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA PYURIA 2
C PNEUMOCYSTIS JIROVECI PNEUMONIA WHITE BLOOD CELL COUNT INCREASED 2
C PREMEDICATION ASPERGILLOSIS 4
C PREMEDICATION BACTERIAL INFECTION 4
C PREMEDICATION CANDIDIASIS 4
C PREMEDICATION CHRONIC GRAFT VERSUS HOST DISEASE 4
C PREMEDICATION CYTOMEGALOVIRUS INFECTION 4
C PREMEDICATION LIVER DISORDER 4
C PREMEDICATION PYREXIA 4
C PREMEDICATION VIRAL INFECTION 4
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD BILIRUBIN INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION C-REACTIVE PROTEIN INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION JAUNDICE 2
C PRODUCT USED FOR UNKNOWN INDICATION OXYGEN SATURATION DECREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION PLEURAL EFFUSION 2
C PRODUCT USED FOR UNKNOWN INDICATION PNEUMONIA 2
C PRODUCT USED FOR UNKNOWN INDICATION WHITE BLOOD CELL COUNT INCREASED 2
C PROPHYLAXIS ASPERGILLOSIS 8
C PROPHYLAXIS BACK PAIN 2
C PROPHYLAXIS BACTERIAL INFECTION 8
C PROPHYLAXIS BLOOD BILIRUBIN INCREASED 2
C PROPHYLAXIS C-REACTIVE PROTEIN INCREASED 2
C PROPHYLAXIS CALCULUS URETERIC 2
C PROPHYLAXIS CANDIDIASIS 8
C PROPHYLAXIS CHILLS 2
C PROPHYLAXIS CHRONIC GRAFT VERSUS HOST DISEASE 8
C PROPHYLAXIS CYTOMEGALOVIRUS INFECTION 8
C PROPHYLAXIS EPILEPSY 15
C PROPHYLAXIS FEELING HOT 2
C PROPHYLAXIS GRANULOCYTOPENIA 15
C PROPHYLAXIS HAEMOGLOBIN DECREASED 15
C PROPHYLAXIS JAUNDICE 2
C PROPHYLAXIS LIVER DISORDER 8
C PROPHYLAXIS OXYGEN SATURATION DECREASED 2
C PROPHYLAXIS PLEURAL EFFUSION 2
C PROPHYLAXIS PNEUMONIA 2
C PROPHYLAXIS PYELONEPHRITIS ACUTE 2
C PROPHYLAXIS PYREXIA 8
C PROPHYLAXIS PYURIA 2
C PROPHYLAXIS STAPHYLOCOCCAL INFECTION 15
C PROPHYLAXIS UTERINE LEIOMYOMA 15
C PROPHYLAXIS VIRAL INFECTION 8
C PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 15
C PROPHYLAXIS WHITE BLOOD CELL COUNT INCREASED 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ASPERGILLOSIS 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE BACTERIAL INFECTION 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE CANDIDIASIS 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE CHRONIC GRAFT VERSUS HOST DISEASE 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE CYTOMEGALOVIRUS INFECTION 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE LIVER DISORDER 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PYREXIA 5
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE VIRAL INFECTION 5
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION EPILEPSY 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION GRANULOCYTOPENIA 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION HAEMOGLOBIN DECREASED 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION STAPHYLOCOCCAL INFECTION 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION UTERINE LEIOMYOMA 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION WHITE BLOOD CELL COUNT DECREASED 3
Ads by Google